Literature DB >> 22328948

Blood cell counts and their correlation with creatine kinase and C-reactive protein in patients with acute myocardial infarction.

Haseeb A Khan, Abdullah S Alhomida, Samia H Sobki, Abdulrahman Al Moghairi, Hatim El Koronki.   

Abstract

This study reports differential blood cells counts and their correlations with creatine kinase (CK) and C-reactive protein (CRP) levels in acute myocardial infarction (AMI) patients and normal subjects. Peripheral blood samples were obtained from all 39 AMI patients and 35 controls for blood cell counts and CK and CRP analyses. Total WBC, WBC fractions, RBC and platelets were measured with an automated hematology analyzer. The results showed a significant increase in total WBC (8.688 × 10(9)/L versus 6.148 × 10(9)/L), monocytes (1.271 versus 0.497 × 10(9)/L), and neutrophils (8.367 versus 3.223 × 10(9)/L) counts in AMI patients than controls. The RBC count was significantly less in AMI patients (4.638 × 10(12)/L) as compared to controls (5.105 × 10(12)/L). However, there was no significant difference in lymphocytes, eosinophils, basophils and platelet counts between AMI patients and controls. Both, serum CK (215.38 ± 43.15 versus 100.82 ± 8.86 U/L) and CRP (29.49 ± 7.61 versus 3.48 ± 0.60 mg/L) were significantly higher in AMI patients as compared to controls. Age of the subjects was neither correlated with blood cell counts nor CK indicating the validity of these markers irrespective of patient age. A significant correlation was observed between WBC counts and CK (R = 0.242, P = 0.041) as well as CRP (R = 0.416, P = 0.000). In conclusion, this study clearly showed significant increase in total and differential leukocyte counts indicating a pro-inflammatory cascade in AMI patients. A significant correlation between WBC counts and CK or CRP levels suggest a possible biomarker value of WBC for a quick prediction of both myocardial necrosis and inflammation in AMI patients.

Entities:  

Keywords:  Acute myocardial infarction; biomarker; blood cells count; creatine kinase; inflammation

Year:  2012        PMID: 22328948      PMCID: PMC3272686     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  36 in total

1.  Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention.

Authors:  Sandro Cadaval Goncalves; Marino Labinaz; Michel Le May; Chris Glover; Michael Froeschl; Jean-Francois Marquis; Edward O'Brien; Dino Shukla; Peter Ruchin; Dharmendra Sookur; Andrew Ha; Derek So
Journal:  Am J Cardiol       Date:  2010-12-02       Impact factor: 2.778

2.  Which white blood cell subtypes predict increased cardiovascular risk?

Authors:  Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

3.  Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction.

Authors:  Birgit A Steppich; Gabriele Demetz; Stefanie Schulz; Jasper von Wedel; Giesela Pogatsa-Murray; Siegmund-Lorenz Braun; Andreas Stein; Adnan Kastrati; Albert Schömig; Ilka Ott
Journal:  Thromb Res       Date:  2010-11-23       Impact factor: 3.944

4.  High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.

Authors:  Giuseppe Ferrante; Masataka Nakano; Francesco Prati; Giampaolo Niccoli; Maria T Mallus; Vito Ramazzotti; Rocco A Montone; Frank D Kolodgie; Renu Virmani; Filippo Crea
Journal:  Circulation       Date:  2010-11-29       Impact factor: 29.690

5.  Blood cells characteristics as determinants of acute myocardial infarction.

Authors:  Roberto Cemin; Luca Donazzan; Giuseppe Lippi; Francesca Clari; Massimo Daves
Journal:  Clin Chem Lab Med       Date:  2011-05-02       Impact factor: 3.694

6.  [The change of platelet number in patient with acute myocardial infarction and its clinical significance].

Authors:  Y Pan; B Wu; X Hong
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1995-01

7.  Pro/Anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling.

Authors:  Anna Laura Pasqui; Pasqui Anna Laura; Michela Di Renzo; Di Renzo Michela; Silvia Maffei; Maffei Silvia; Marcello Pastorelli; Pastorelli Marcello; Gerarda Pompella; Pompella Gerarda; Alberto Auteri; Auteri Alberto; Luca Puccetti; Puccetti Luca
Journal:  Mediators Inflamm       Date:  2010-05-09       Impact factor: 4.711

8.  Peripheral monocytosis following acute myocardial infarction: incidence and its possible role as a bedside marker of the extent of cardiac injury.

Authors:  S R Meisel; H Pauzner; M Shechter; Z Zeidan; D David
Journal:  Cardiology       Date:  1998-07       Impact factor: 1.869

9.  Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program.

Authors:  Norma Maugeri; Patrizia Rovere-Querini; Virgilio Evangelista; Cesare Covino; Annalisa Capobianco; Maria T S Bertilaccio; Antonio Piccoli; Licia Totani; Domenico Cianflone; Attilio Maseri; Angelo A Manfredi
Journal:  Blood       Date:  2009-03-04       Impact factor: 22.113

10.  Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.

Authors:  Britta U Goldmann; Volker Rudolph; Tanja K Rudolph; Ann-Katrin Holle; Matthias Hillebrandt; Thomas Meinertz; Stephan Baldus
Journal:  Free Radic Biol Med       Date:  2009-04-09       Impact factor: 7.376

View more
  10 in total

1.  Neutrophil-to-lymphocyte ratio (NLR) predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people.

Authors:  Jingyu He; Jing Li; Yunfei Wang; Peng Hao; Qi Hua
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Serum levels of thrombotic markers in patients with acute myocardial infarction.

Authors:  Shafiqul Islam; Sobhy M Yakout; Nasser M Al Daghri; Abdullah S Alhomida; Haseeb A Khan
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Investigation of mean platelet volume in patients with type 2 diabetes mellitus and in subjects with impaired fasting glucose: a cost-effective tool in primary health care?

Authors:  Aclan Ozder; Hasan Huseyin Eker
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 4.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

5.  Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris.

Authors:  Zhen-Xing Zhou; Jian-Kui Chen; Yan-Ying Hong; Ru Zhou; Dong-Mei Zhou; Li-Yun Sun; Wen-Li Qin; Tian-Cheng Wang
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

Review 6.  Endobiogeny: a global approach to systems biology (part 2 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat; Patrice Pauly
Journal:  Glob Adv Health Med       Date:  2013-03

7.  Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and MiRNA profiles.

Authors:  Madlen Häntzsch; Alexander Tolios; Frank Beutner; Dorothea Nagel; Joachim Thiery; Daniel Teupser; Lesca M Holdt
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

Review 8.  Potential of lipoproteins as biomarkers in acute myocardial infarction.

Authors:  Haseeb Ahmad Khan; Aishah Ekhzaimy; Isra Khan; Meena Kishore Sakharkar
Journal:  Anatol J Cardiol       Date:  2017-07       Impact factor: 1.596

9.  Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction.

Authors:  Tian-Meng Chen; Jian Li; Lin Liu; Li Fan; Xiao-Ying Li; Yu-Tang Wang; Nader G Abraham; Jian Cao
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

10.  A novel indicator predicts 2019 novel coronavirus infection in subjects with diabetes.

Authors:  Aclan Ozder
Journal:  Diabetes Res Clin Pract       Date:  2020-07-03       Impact factor: 5.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.